Iovance Biotherapeutics shares are trading higher after Director Wayne Rothbaum reported a purchase of 10 million shares at an average price of $6.50 in a Form 4 filing on Friday. $Iovance(IOVA)$ ![[为什么]](http://assets.imedao.com/ugc/images/face/emoji_14_doubt.png?v=1 "[为什么]"){kind=small}
| 发布于: | Android | 转发：1 | 回复：0 | 喜欢：0 |
Iovance Biotherapeutics shares are trading higher after Director Wayne Rothbaum reported a purchase of 10 million shares at an average price of $6.50 in a Form 4 filing on Friday. $Iovance(IOVA)$